Meta-analysis identifies seven susceptibility loci involved in the atopic march

Nature Communications - Tập 6 Số 1
Ingo Marenholz1,2, Jorge Esparza-Gordillo1,2, Franz Rüschendorf2, Anja Bauerfeind2, David P. Strachan3, Ben D. Spycher4, Hansjörg Baurecht5, Patricia Margaritte‐Jeannin6,7, Annika Sääf8, Marjan Kerkhof9, Markus Ege10, Svetlana Baltic11, Melanie C. Matheson12, Jin Li13, Sven Michel14, Wei Ang15, Wendy L. McArdle16, Andreas Arnold17, Georg Homuth18, Florence Démenais6,7, Emmanuelle Bouzigon6,7, Cilla Söderhäll19, Göran Pershagen8, Johan C. de Jongste20, Dirkje S. Postma21, Charlotte Braun‐Fahrländer22, Elisabeth Horak23, Л. М. Огородова24, В. П. Пузырев25,24, E. Yu. Bragina25, Thomas J. Hudson26, Charles Morin27, David L. Duffy28, Guy B. Marks29, Colin Robertson30, Grant W. Montgomery28, Bill Musk31, Philip J. Thompson11, Nicholas G. Martin28, Anthony James31, Patrick Sleiman13,32, Elina Toskala33, Elke Rodríguez5, Regina Fölster‐Holst5, André Franke34, Wolfgang Lieb35, Christian Gieger36, Andrea Heinzmann37, Ernst Rietschel38, Thomas Keil39,40, Sven Cichon41,42,43,44, Markus M. Nöthen41,43, Craig E. Pennell15, Peter D. Sly45, Carsten Oliver Schmidt46, Anja Matanovic1,2, Valentin Schneider-Lunitz2, Matthias Heinig47,2, Norbert Hübner2, Patrick G. Holt45,48, Susanne Lau49, Michael Kabesch14, Stephan Weidinger5, Hákon Hákonarson13,32, Manuel A. R. Ferreira28, Catherine Laprise50, Maxim B. Freidin25, Jon Genuneit51, Gerard H. Koppelman52, Erik Melén8,53, Marie‐Hélène Dizier6,7, A. John Henderson16, Young Ae Lee1,2
1Clinic for Pediatric Allergy, Experimental and Clinical Research Center, Charité University Medical Center, Berlin, Germany
2Max-Delbrück-Center (MDC) for Molecular Medicine, Berlin, Germany
3Population Health Research Institute, St George's, University of London, London, UK
4Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
5Department of Dermatology, Allergology, and Venerology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
6Inserm, UMR-946, Paris, France
7Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie, Paris, France
8Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
9University of Groningen, University Medical Center Groningen, GRIAC research institute, Groningen, The Netherlands
10Dr von Hauner Children’s Hospital, Ludwig Maximilians University Munich, Member of the German Center for Lung Research (DZL), Munich, Germany
11Lung Institute of Western Australia, University of Western Australia, Perth, Australia
12Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Australia
13Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, USA
14Department of Pediatric Pneumology and Allergy, University Children’s Hospital Regensburg (KUNO), Regensburg, Germany
15School of Women and Infant’s Health, University of Western Australia, Perth, Australia
16School of Social and Community Medicine, University of Bristol, Bristol, UK
17Clinic and Polyclinic of Dermatology, University Medicine Greifswald, Greifswald, Germany
18Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine and Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany
19Department of Biosciences and Nutrition, and Center for Innovative Medicine (CIMED), Karolinska Institutet, Stockholm, Sweden
20Department of Pediatrics, Pediatric Chest Center, Erasmus University Medical Center, Rotterdam, The Netherlands
21Department of Pulmonology and GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
22Swiss Tropical and Public Health Institute and the University of Basel, Basel, Switzerland
23Division of Pediatric Cardiology and Pulmonology, Department of Pediatrics, Innsbruck Medical University, Innsbruck, Austria
24Siberian State Medical University, Tomsk, Russia
25Research Institute of Medical Genetics, Tomsk, Russia
26Ontario Institute for Cancer Research, Toronto, Canada
27Centre de santé et de services sociaux de Chicoutimi, Saguenay, Canada
28QIMR Berghofer Medical Research Institute, Brisbane, Australia
29Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
30Department of Respiratory Medicine, Murdoch Children’s Research Institute, Melbourne, Australia
31Busselton Population Medical Research Foundation, Sir Charles Gairdner Hospital, Perth, Australia
32Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
33Department of Otolaryngology-Head and Neck Surgery, Temple University, School of Medicine, Philadelphia, USA
34Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany
35Institute of Epidemiology, Christian-Albrechts-University of Kiel, Kiel, Germany
36Research Unit of Molecular Epidemiology and Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
37University Children’s Hospital, Albert Ludwigs University, Freiburg, Germany
38University Children's Hospital, University of Cologne, Cologne, Germany
39Institute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany
40Institute of Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Berlin, Germany
41Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany
42Division of Medical Genetics, University Hospital Basel and Department of Biomedicine, University of Basel, Basel, Switzerland
43Institute of Human Genetics, University of Bonn, Bonn, Germany
44Institute of Neuroscience and Medicine (INM-1), Structural and Functional Organisation of the Brain, Genomic Imaging, Research Centre Jülich, Jülich, Germany
45Queensland Children's Medical Research Institute, University of Queensland, Brisbane, Australia
46Institute for Community Medicine, Study of Health in Pomerania/KEF, University Medicine Greifswald, Greifswald, Germany
47Max Planck Institute for Molecular Genetics, Berlin, Germany
48Telethon Kids Institute, University of Western Australia, Perth, Australia
49Department of Pediatric Pneumology and Immunology, Charité University Medical Center, Berlin, Germany
50Université du Québec à Chicoutimi, Saguenay, Canada
51Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany
52Department of Pediatric Pulmonology and Pediatric Allergology, University of Groningen, University Medical Center Groningen, Beatrix Children’s Hospital and GRIAC Research Institute, Groningen, The Netherlands
53Sachs’ Children’s Hospital, Stockholm, Sweden

Tóm tắt

Abstract

Eczema often precedes the development of asthma in a disease course called the ‘atopic march’. To unravel the genes underlying this characteristic pattern of allergic disease, we conduct a multi-stage genome-wide association study on infantile eczema followed by childhood asthma in 12 populations including 2,428 cases and 17,034 controls. Here we report two novel loci specific for the combined eczema plus asthma phenotype, which are associated with allergic disease for the first time; rs9357733 located in EFHC1 on chromosome 6p12.3 (OR 1.27; P=2.1 × 10−8) and rs993226 between TMTC2 and SLC6A15 on chromosome 12q21.3 (OR 1.58; P=5.3 × 10−9). Additional susceptibility loci identified at genome-wide significance are FLG (1q21.3), IL4/KIF3A (5q31.1), AP5B1/OVOL1 (11q13.1), C11orf30/LRRC32 (11q13.5) and IKZF3 (17q21). We show that predominantly eczema loci increase the risk for the atopic march. Our findings suggest that eczema may play an important role in the development of asthma after eczema.

Từ khóa


Tài liệu tham khảo

Dharmage, S. C. et al. Atopic dermatitis and the atopic march revisited. Allergy 69, 17–27 (2014).

Spergel, J. M. From atopic dermatitis to asthma: the atopic march. Ann. Allergy Asthma Immunol. 105, 99–106 (2010).

Almqvist, C. et al. Early predictors for developing allergic disease and asthma: examining separate steps in the ‘allergic march’. Clin. Exp. Allergy 37, 1296–1302 (2007).

Ricci, G. et al. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases. J. Am. Acad. Dermatol. 55, 765–771 (2006).

Leung, D. Y. & Guttman-Yassky, E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J. Allergy Clin. Immunol. 134, 769–779 (2014).

Li, M. Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march. Eur. Respir. Rev. 23, 292–298 (2014).

Kemeny, L. & Szabo, K. Toll-like receptors link atopic march to the hygiene hypothesis. J. Invest. Dermatol. 133, 874–878 (2013).

Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38, 441–446 (2006).

Marenholz, I. et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J. Allergy Clin. Immunol. 118, 866–871 (2006).

Punekar, Y. S. & Sheikh, A. Establishing the sequential progression of multiple allergic diagnoses in a UK birth cohort using the General Practice Research Database. Clin. Exp. Allergy 39, 1889–1895 (2009).

Freedman, M. L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388–393 (2004).

Paternoster, L. et al. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat. Genet. 44, 187–192 (2012).

Marenholz, I. et al. The eczema risk variant on chromosome 11q13 (rs7927894) in the population-based ALSPAC cohort: a novel susceptibility factor for asthma and hay fever. Hum. Mol. Genet. 20, 2443–2449 (2011).

Esparza-Gordillo, J. et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat. Genet. 41, 596–601 (2009).

Moffatt, M. F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470–473 (2007).

Bisgaard, H. et al. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am. J. Respir. Crit. Care Med. 179, 179–185 (2009).

Halapi, E. et al. A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur. J. Hum. Genet. 18, 902–908 (2010).

Hinds, D. A. et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat. Genet. 45, 907–911 (2013).

Ferreira, M. A. et al. Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J. Allergy Clin. Immunol. 133, 1564–1571 (2014).

Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506–511 (2013).

ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).

Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).

Eppig, J. T., Blake, J. A., Bult, C. J., Kadin, J. A. & Richardson, J. E. The Mouse Genome Database (MGD): facilitating mouse as a model for human biology and disease. Nucleic Acids Res. 43, D726–D736 (2015).

Forrest, A. R. et al. A promoter-level mammalian expression atlas. Nature 507, 462–470 (2014).

Johnson, A. D. et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938–2939 (2008).

Sunryd, J. C. et al. TMTC1 and TMTC2 are novel endoplasmic reticulum tetratricopeptide repeat-containing adapter proteins involved in calcium homeostasis. J. Biol. Chem. 289, 16085–16099 (2014).

Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001–D1006 (2014).

Medina, M. T. et al. Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy. Neurology 70, 2137–2144 (2008).

Annesi, F. et al. Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsy. Epilepsia 48, 1686–1690 (2007).

Ma, S. et al. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res. 71, 129–134 (2006).

Stogmann, E. et al. Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations. Neurology 67, 2029–2031 (2006).

Suzuki, T. et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat. Genet. 36, 842–849 (2004).

Suzuki, T. et al. Efhc1 deficiency causes spontaneous myoclonus and increased seizure susceptibility. Hum. Mol. Genet. 18, 1099–1109 (2009).

Ikeda, T. et al. The mouse ortholog of EFHC1 implicated in juvenile myoclonic epilepsy is an axonemal protein widely conserved among organisms with motile cilia and flagella. FEBS Lett. 579, 819–822 (2005).

Thomas, B. et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J. Allergy Clin. Immunol. 126, 722–729 (2010).

Silverberg, J. I., Joks, R. & Durkin, H. G. Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy 69, 95–103 (2014).

Drgonova, J. et al. Involvement of the neutral amino acid transporter SLC6A15 and leucine in obesity-related phenotypes. PLoS ONE 8, e68245 (2013).

Schuhmacher, A. et al. A variant of the neuronal amino acid transporter SLC6A15 is associated with ACTH and cortisol responses and cognitive performance in unipolar depression. Int. J. Neuropsychopharmacol. 16, 83–90 (2013).

Kohli, M. A. et al. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 70, 252–265 (2011).

Cuboni, S. et al. Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2. J. Med. Chem. 57, 9473–9479 (2014).

Pasparakis, M., Haase, I. & Nestle, F. O. Mechanisms regulating skin immunity and inflammation. Nat. Rev. Immunol. 14, 289–301 (2014).

Kawasaki, H. et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J. Allergy Clin. Immunol. 129, 1538–1546 (2012).

Spergel, J. M. et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101, 1614–1622 (1998).

Horimukai, K. et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J. Allergy Clin. Immunol. 134, 824–830 (2014).

Simpson, E. L. et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J. Allergy Clin. Immunol. 134, 818–823 (2014).

Ballardini, N. et al. Infantile eczema: prognosis and risk of asthma and rhinitis in preadolescence. J. Allergy Clin. Immunol. 133, 594–596 (2014).

Saunes, M. et al. Early eczema and the risk of childhood asthma: a prospective, population-based study. BMC Pediatr. 12, 168 (2012).

von Kobyletzki, L. B. et al. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol. 12, 11 (2012).

Martin, P. E. et al. Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades. J. Allergy Clin. Immunol. 127, 1473–1479 (2011).

Belgrave, D. C. et al. Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies. PLoS Med. 11, e1001748 (2014).

Noti, M. et al. Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. J. Allergy Clin. Immunol. 133, 1390–1399 (2014).

Bihouee, T. et al. Food allergy enhances allergic asthma in mice. Respir. Res. 15, 142 (2014).

Longo, G., Berti, I., Burks, A. W., Krauss, B. & Barbi, E. IgE-mediated food allergy in children. Lancet 382, 1656–1664 (2013).

Chafen, J. J. et al. Diagnosing and managing common food allergies: a systematic review. JAMA 303, 1848–1856 (2010).

Keil, T. et al. The multinational birth cohort of EuroPrevall: background, aims and methods. Allergy 65, 482–490 (2010).

Rona, R. J. et al. The prevalence of food allergy: a meta-analysis. J. Allergy Clin. Immunol. 120, 638–646 (2007).

Ramasamy, A. et al. A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J. Allergy Clin. Immunol. 128, 996–1005 (2011).

Spergel, J. M. Epidemiology of atopic dermatitis and atopic march in children. Immunol. Allergy Clin. North Am. 30, 269–280 (2010).

Kapoor, R. et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J. Am. Acad. Dermatol. 58, 68–73 (2008).

van der Hulst, A. E., Klip, H. & Brand, P. L. Risk of developing asthma in young children with atopic eczema: a systematic review. J. Allergy Clin. Immunol. 120, 565–569 (2007).

Moffatt, M. F. et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363, 1211–1221 (2010).

Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).

Li, Y., Willer, C. J., Ding, J., Scheet, P. & Abecasis, G. R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816–834 (2010).

Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).

Williams, R. L. A note on robust variance estimation for cluster-correlated data. Biometrics 56, 645–646 (2000).

Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).

Henderson, J. et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J. Allergy Clin. Immunol. 121, 872–877 (2008).

Ballardini, N. et al. Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort. Br. J. Dermatol. 168, 588–594 (2013).

Schuttelaar, M. L. et al. Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy 64, 1758–1765 (2009).

Sandilands, A. et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat. Genet. 39, 650–654 (2007).